We are live on ! Find out more
SWTX

SpringWorks Therapeutics

Delisted

SWTX was delisted on the 30th of June, 2025.

137 hedge funds and large institutions have $3.23B invested in SpringWorks Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

11% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 46

10% more funds holding

Funds holding: 124137 (+13)

3% more capital invested

Capital invested by funds: $3.13B → $3.23B (+$103M)

0.72% more ownership

Funds ownership: 88.96%89.68% (+0.72%)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
51
Reduced
46
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Aviva
76
Aviva
United Kingdom
$1.34M +$1.43M +18,279 New
Wells Fargo
77
Wells Fargo
California
$1.32M -$1.24M -15,890 -47%
SG Americas Securities
78
SG Americas Securities
New York
$1.24M -$485K -6,198 -27%
Susquehanna International Group
79
Susquehanna International Group
Pennsylvania
$1.17M +$225K +2,878 +22%
JP Morgan Chase
80
JP Morgan Chase
New York
$1.12M +$337K +4,309 +40%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
81
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.1M +$1.17M +15,000 New
Principal Financial Group
82
Principal Financial Group
Iowa
$1.08M -$22.4K -286 -2%
Two Sigma Advisers
83
Two Sigma Advisers
New York
$1.04M +$1.11M +14,200 New
DekaBank Deutsche Girozentrale
84
DekaBank Deutsche Girozentrale
Germany
$1.04M
Legal & General Group
85
Legal & General Group
United Kingdom
$1.04M +$833K +10,635 +301%
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.02M -$60.1K -768 -5%
SO
87
STRS Ohio
Ohio
$1.01M
CS
88
Credit Suisse
Switzerland
$993K -$1.74M -22,264 -62%
ProShare Advisors
89
ProShare Advisors
Maryland
$971K +$27.2K +347 +3%
CC
90
Centiva Capital
New York
$959K -$62.3K -796 -6%
Squarepoint
91
Squarepoint
New York
$946K -$374K -4,781 -27%
Natixis Advisors
92
Natixis Advisors
Massachusetts
$894K +$952K +12,152 New
EAM
93
Erste Asset Management
Austria
$842K
Prudential Financial
94
Prudential Financial
New Jersey
$797K +$849K +10,835 New
SMH
95
Sanders Morris Harris
Texas
$787K
VOYA Investment Management
96
VOYA Investment Management
Georgia
$775K +$38.8K +496 +5%
HS
97
HighVista Strategies
Massachusetts
$711K -$215K -2,743 -22%
MIM
98
MetLife Investment Management
New Jersey
$709K
State Board of Administration of Florida Retirement System
99
State Board of Administration of Florida Retirement System
Florida
$627K +$9.4K +120 +1%
Tudor Investment Corp
100
Tudor Investment Corp
Connecticut
$591K +$629K +8,031 New

SWTX Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2021, worth a combined $3.23B — up 3.3% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 12 closed out — a net gain of 13 holders — while 51 added to existing stakes and 46 trimmed.

The largest buyer was Vanguard Group, adding an estimated $95.8M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $114M.

  • 137 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2021, up from 124 in Q4 2020.
  • Funds reported $3.23B of SpringWorks Therapeutics stock for Q1 2021, up 3.3% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q1 2021 and 12 closed out, a net change of +13 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $95.8M added.
  • The largest SpringWorks Therapeutics seller in Q1 2021 was Bain Capital Life Sciences Investors, an estimated $114M sold.

Based on aggregated 13F filings for Q1 2021.